• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

LKT Labs

Biochemicals for Life Science Research

  • Products
    • New Products
    • Cancer Biology
    • Cardiovascular
    • Endocrine Signaling and Immunology
    • Metabolic and GI Pathology
    • Microbiology
    • Natural Products
    • Neuroscience
    • Peptides
    • Pharmaceutical Impurities and Derivatives
    • Stem Cell Modulators
  • Services
    • Custom Synthesis
    • Natural Product Isolation
    • Analytical Services
  • Int’l Distributors
  • Support
    • About LKT Labs
    • General Inquiry
    • Bulk Quote Request
    • Document Request
    • Technical Support
    • Catalog Request
    • Product Flyers
  • Contact Us
  • Cart
  • Login / Register
Home | Biochemicals | Cancer Biology | Anticancer | Tyrosine Kinase Inhibitors | src

src

Product ID
Name
Description
Purity
  • B5874

    Bosutinib

    Src and Abl inhibitor.

    ≥98%
  • B5875

    Bosutinib, structural isomer

    Bosutinib isomer; Src and Abl inhibitor.

    ≥98%
  • C104761

    CCT-196969

    pan-Raf inhibitor.

    ≥98%
  • D023721

    Dasatinib

    Multikinase inhibitor.

    ≥99%
  • D0375

    Dasatinib Monohydrate

    Abl, PDGFR, EphR, Src, k-Kit, FYN, LCK, HCK inh...

    ≥98%
  • D0808

    DCC-2036

    Abl inhibitor.

    ≥98%
  • H1669

    Herbimycin A

    Benzoquinone ansamycin; HSP90, PKC, Src, Bcr-Ab...

    ≥98%
  • K9200

    KX1-004

    Indole; Src inhibitor.

    ≥98%
  • P577520

    Ponatinib

    pan-Bcr-Abl tyrosine kinase inhibitor.

    ≥99%
  • P6002

    PP-121

    p110α PI3K, DNA-PK, mTOR, Abl, Hck, Src, VEGFR...

    ≥98%
  • R0020

    RAF265

    B-Raf, VEGFR2, c-Raf, PDGFR, CSF-1R, RET, c-Kit...

    ≥98%
  • S0168

    Saracatinib

    Src and Abl inhibitor.

    ≥98%

Showing all 12 results

sidebar

Store Sidebar

Product Categories

  • Biochemicals (3113)
    • Cancer Biology (1463)
      • Anti-angiogenic (185)
      • Anti-metastatic (86)
      • Anticancer (1207)
        • Anti-mitotics (64)
        • Compounds targeting DNA synthesis and repair (104)
        • DNA Crosslinking and Alkylating Agents (30)
        • Epigenetic Modifiers (54)
        • Hormone Receptor Modulators (37)
        • Inhibitors of other enzymes (83)
        • Nucleoside and Nucleotide Analogs (26)
        • Serine/Threonine Kinase Inhibitors (61)
        • Transcription Factor Modifiers (106)
        • Tyrosine Kinase Inhibitors (151)
          • Abl (17)
          • ALK (19)
          • Axl (5)
          • BTK (4)
          • c-kit (15)
          • c-met (13)
          • EGFR (35)
          • ephR (2)
          • FAK (5)
          • FGFR (10)
          • FLT (11)
          • FYN (2)
          • IGF-1R (8)
          • JAK (20)
          • LCK (3)
          • PDGFR (25)
          • RET (12)
          • Ron (5)
          • ROS1 (5)
          • src (12)
          • TIE (4)
          • TRK (3)
          • VEGFR (27)
      • Antioxidant (370)
      • Carcinogens and Mutagens (40)
      • Chemopreventive (163)
    • Cardiovascular (465)
    • Endocrine Signaling and Immunology (1080)
    • Metabolic and GI Pathology (383)
    • Microbiology (672)
    • Natural Products (728)
    • Neuroscience (770)
    • Peptides (578)
    • Pharmaceutical Impurities and Derivatives (73)
    • Stem Cell Modulators (21)
  • New Products (59)
  • Other Products (70)
  • Uncategorized (10)

Footer

  • Contact Us
  • About Us
  • Site Map
  • Terms and Conditions
LKT Laboratories, Inc.
545 Phalen Blvd.
St. Paul MN, 55130

Ph: (888)-558-5227
Fax: (888)-558-7329

©2025 LKT Laboratories, All Rights Reserved - Products for research use only